Hollings Renton, President and CEO at ONYX PHARMACEUTICALS INC (ONXX), sold 667 shares at $36.68 ($24K) on 2008-02-19, disclosed to the SEC on 2008-02-21.
Scheduled sale ($24k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.67 | 600 | $21K | 89.7% |
| 2 | $36.68 | 67 | $2K | 10.3% |
| Total | $35.77 avg | 667 | $24K | 100% |
| Filing → |
| ANAB | SELL | 2025-06-20 | $145K | — | Filing → |
| ANAB | SELL | 2024-12-03 | $250K | — | Filing → |
| ANAB | SELL | 2024-07-17 | $613K | — | Filing → |